Advertisement

Topics

FDA panel backs Allergan's drug for frequent nightly urination

12:13 EDT 19 Oct 2016 | Reuters

(Reuters) - The benefits associated with Allergan Plc's experimental drug to treat frequent nightly urination outweigh the risks for certain patients, an advisory panel to the U.S. Food and Drug Administration concluded on Wednesday.

Original Article: FDA panel backs Allergan's drug for frequent nightly urination

NEXT ARTICLE

More From BioPortfolio on "FDA panel backs Allergan's drug for frequent nightly urination"

Quick Search
Advertisement
 

Relevant Topic

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...